Skip to main content
Premium Trial:

Request an Annual Quote

Heiner Dreismann

Nucleix has appointed Heiner Dreismann to the company's board of directors. Currently, he serves on the boards of several public and private healthcare companies. From 1985 to 2006, Dreismann has held several senior positions at the Roche Group, including president and CEO of Roche Molecular Systems, head of global business development at Roche Diagnostics and a member of Roche's global diagnostic executive committee.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.